Association between Certain NSCLC Driver Mutations and Predictive Markers for Chemotherapy or PD-(L)1 Inhibition
Cancer science, 2019.
PD-(L)1chemotherapygene mutationlung cancerpredictive markers
This study aimed to analyze the association between driver mutations and predictive markers for some anti-tumor agents in non-small cell lung cancer (NSCLC). A cohort of 785 Chinese patients with NSCLC who underwent resection from March 2016 to November 2017 in the First Affiliated Hospital of Guangzhou Medical University was investigated...More
Full Text (Upload PDF)